Literature DB >> 33641253

Bupivacaine infiltration for acute postoperative pain management after cardiac surgery.

Manuel Luque Oliveros1, Rubén Morilla Romero de la Osa1,2.   

Abstract

BACKGROUND: Despite increased attention, acute and persistent post-operative pain are not treated efficiently and interventions against acute pain are therefore of clinical importance and should be welcomed. AIMS AND
OBJECTIVES: To evaluate the effectiveness of wound infiltration with 0.5% bupivacaine for pain management in the immediate post-operative period in patients that underwent cardiac surgery with sternotomy.
DESIGN: The study was performed employing a single-centre nonrandomized experimental design to evaluate a prospective cohort of patients recruited from June to December of 2017.
METHODS: A single-centre study with a non-randomized experimental design compared the pain perceived by 137 patients undergoing to cardiac surgery within which 68 patients who received infiltration of bupivacaine and 69 patients received infiltration with saline solution. Pain measures were made with the numeric rating scale (NRS) at 2, 12, 24, and 48 hours. Socio-demographic and clinical variables were included too and descriptive, bivariate, and multivariate logistic regression analyses were performed.
RESULTS: A statistically significant difference was found between the means of the NRS scores in favour of the intervention group. Cohen's d showed a significant effect size. NRS scores were grouped into NRS ≥4 or NRS <4 and similar results were found. Multivariate logistic regression analyses showed the absence of confounding factors that could call results into question.
CONCLUSION: Subcutaneous infiltration of 0.5% bupivacaine in the surgical site of patients who have undergone cardiac surgery showed clinically and statistically significant pain relief compared with patients who received saline infiltration throughout the first 12 hours after surgery. This intervention provides promising preliminary results that, alone or in conjunction with other nursing interventions, could constitute an important therapeutic tool for this area of nursing clinical practice.
© 2021 British Association of Critical Care Nurses.

Entities:  

Keywords:  acute pain; bupivacaine; nursing; pain management; postoperative pain

Mesh:

Substances:

Year:  2021        PMID: 33641253     DOI: 10.1111/nicc.12614

Source DB:  PubMed          Journal:  Nurs Crit Care        ISSN: 1362-1017            Impact factor:   2.325


  1 in total

1.  MiRNA-494-3p Regulates Bupivacaine-Induced Neurotoxicity by the CDK6-PI3K/AKT Signaling.

Authors:  Licheng Zhang; Lifeng Zhang; Fengying Guo
Journal:  Neurotox Res       Date:  2021-10-15       Impact factor: 3.911

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.